{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:22:13Z","timestamp":1794298933871,"version":"4.9.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"WHO office in Iran"},{"name":"Iranian Ministry of Health and Medical Education","id":[{"id":"https:\/\/ror.org\/01rs0ht88","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05992-6","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:04:51Z","timestamp":1779681891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["National program for cardiovascular disease and hypertension in primary healthcare: WHO-PEN program initial scale-up in Iran (IraPEN)"],"prefix":"10.1186","volume":"26","author":[{"given":"Davood","family":"Khalili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1086-0907","authenticated-orcid":false,"given":"Leila","family":"Molaeipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4005-9563","authenticated-orcid":false,"given":"Koorosh","family":"Etemad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza Mahdavi","family":"Hezaveh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Hadaegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooba","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8098-7121","authenticated-orcid":false,"given":"Farzad","family":"Masoudkabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-4610","authenticated-orcid":false,"given":"Kazem","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Heshmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8670-5797","authenticated-orcid":false,"given":"Afshin","family":"Ostovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6470-2517","authenticated-orcid":false,"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"5992_CR1","unstructured":"World Health Organization. Facts Sheet: Cardiovascular Diseases.: WHO. 2021. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds). Updated 11 June 2021."},{"key":"5992_CR2","unstructured":"World Health Organization. Fact sheet: Hypertension: WHO; 2023. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hypertension. Updated 16 March 2023."},{"issue":"4","key":"5992_CR3","first-page":"204","volume":"22","author":"N Sarrafzadegan","year":"2019","unstructured":"Sarrafzadegan N, Mohammmadifard N. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med. 2019;22(4):204\u201310.","journal-title":"Arch Iran Med"},{"issue":"7","key":"5992_CR4","first-page":"456","volume":"19","author":"A Esteghamati","year":"2016","unstructured":"Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Khajeh E, et al. Awareness, Treatment and Control of Pre-hypertension and Hypertension among Adults in Iran. Arch Iran Med. 2016;19(7):456\u201364.","journal-title":"Arch Iran Med"},{"key":"5992_CR5","unstructured":"World Health Organization. Global action plan for the prevention and control of noncommunicable diseases.: WHO. 2013 [updated 25 August, 2021. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/94384\/9789241506236_eng.pdf?sequence=1"},{"key":"5992_CR6","unstructured":"World Health Organization. Package of Non-communicable Diseases 2020, WHO: 2020. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240009226. Updated April 2020."},{"issue":"5\u20136","key":"5992_CR7","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.26719\/2003.9.5-6.1114","volume":"9","author":"F Azizi","year":"2003","unstructured":"Azizi F, Gouya M, Vazirian P, Dolatshahi P, Habibian S. The diabetes prevention and control programme of the Islamic Republic of Iran. EMHJ-Eastern Mediterranean Health J. 2003;9(5\u20136):1114\u201321.","journal-title":"EMHJ-Eastern Mediterranean Health J"},{"issue":"1","key":"5992_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12889-024-21168-3","volume":"25","author":"S Derakhshan","year":"2025","unstructured":"Derakhshan S, Khalili D, Mahdavi A, Hashemi-Nazari SS, Kavousi A, Hadavandsiri F, et al. Evaluation of the effectiveness of the Iran-package of essential non-communicable disease (IraPEN) program in reducing cardiovascular disease risk in pilot areas. BMC Public Health. 2025;25(1):429.","journal-title":"BMC Public Health"},{"key":"5992_CR9","unstructured":"World Health Organization. Noncommunicable diseases:IraPEN: tailoring the WHO PEN for NCD prevention and control to the national context: WHO; 2021. Available from: https:\/\/www.emro.who.int\/noncommunicable-diseases\/highlights\/irapen-tailoring-the-who-pen-for-ncd-prevention-and-control-to-the-national-context.html. Updated 2021."},{"issue":"1","key":"5992_CR10","first-page":"10","volume":"23","author":"S Derakhshan","year":"2021","unstructured":"Derakhshan S, Khalili D, Etemad K, Nazari SSH, Kavousi A, Hadavand F, et al. Prevalence of cardiovascular risk factors in men and women referred to health centers in the four cities of the Ira-pen pilot program, 2016\u20132017. Iran J Endocrinol Metabolism. 2021;23(1):10\u201321.","journal-title":"Iran J Endocrinol Metabolism"},{"issue":"2","key":"5992_CR11","first-page":"116","volume":"22","author":"F Hadavand Siri","year":"2020","unstructured":"Hadavand Siri F, Khalili D, Hashemi Nazari SS, Ostovar A, Mahdavi A. Adherence to Iran\u2019s package of essential noncommunicable diseases (IraPEN) program for regular follow-up to reduce the risk of cardiovascular disease in healthcare centers. Iran J Endocrinol Metabolism. 2020;22(2):116\u201326.","journal-title":"Iran J Endocrinol Metabolism"},{"key":"5992_CR12","volume-title":"Package of Essential Noncommunicable Diseases in Iran\u2019s primary health care (IraPEN)","author":"Ministry of Health and Medical Education","year":"2018","unstructured":"Ministry of Health and Medical Education. Package of Essential Noncommunicable Diseases in Iran\u2019s primary health care (IraPEN). Tehran: MOHME; 2018."},{"key":"5992_CR13","doi-asserted-by":"publisher","first-page":"1098312","DOI":"10.3389\/fpubh.2023.1098312","volume":"11","author":"F Hadavand Siri","year":"2023","unstructured":"Hadavand Siri F, Khalili D, Mahdavi A, Afkar M, Ostovar A, Hashemi-Nazari SS, et al. Timely referral to health centers for the prevention of cardiovascular diseases: IraPEN national program. Front Public Health. 2023;11:1098312.","journal-title":"Front Public Health"},{"issue":"1","key":"5992_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s40200-024-01550-z","volume":"24","author":"L Molaeipour","year":"2025","unstructured":"Molaeipour L, Koohi F, Ostovar A, Etemad K, Hezaveh AM, Yousefi E, et al. Health indicators in the management of diabetes in Primary health care: Iran-package of Essential Non-communicable diseases (IraPEN) program. J Diabetes Metabolic Disorders. 2025;24(1):40.","journal-title":"J Diabetes Metabolic Disorders"},{"issue":"10","key":"5992_CR15","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1108\/01443570010343708","volume":"20","author":"A Neely","year":"2000","unstructured":"Neely A, Mills J, Platts K, Richards H, Gregory M, Bourne M, et al. Performance measurement system design: developing and testing a process-based approach. Int J Oper Prod Manage. 2000;20(10):1119\u201345.","journal-title":"Int J Oper Prod Manage"},{"key":"5992_CR16","unstructured":"World Health Organization. Country case studies on primary health care: Islamic Republic of Iran.: WHO. 2018 [updated 2018. Available from: https:\/\/www.who.int\/teams\/primary-health-care\/evidence-and-innovation\/primary-health-care-case-study-compendium\/detail\/country-case-studies-on-primary-health-care--islamic-republic-of-iran"},{"key":"5992_CR17","volume-title":"IraPEN, Special training guide for doctors","author":"Ministry of Health and Medical Education","year":"2016","unstructured":"Ministry of Health and Medical Education. IraPEN, Special training guide for doctors. Tehran: Mojassameh; 2016."},{"key":"5992_CR18","unstructured":"Ministry of Health and Medical Education. IraPEN, Behvarz educational content \/ Health care Tehran: Mojasameh; 2016."},{"key":"5992_CR19","doi-asserted-by":"crossref","unstructured":"Djalalinia S, Azadnajafabad S, Ghasemi E, Yoosefi M, Rezaei N, Farzi Y, et al. Protocol design for surveillance of risk factors of non\u2013communicable diseases during the covid-19 pandemic: an experience from Iran STEPS survey 2021. Arch Iran Med. 2022;25(9):634\u201346.","DOI":"10.34172\/aim.2022.99"},{"key":"5992_CR20","doi-asserted-by":"crossref","unstructured":"Albelbeisi AH, Albelbeisi A, El Bilbeisi AH, Taleb M, Takian A, Akbari-Sari A. Public sector capacity to prevent and control of noncommunicable diseases in twelve low-and middle-income countries based on WHO-PEN standards: a systematic review. Health Serv Insights. 2021;14:1\u201311.","DOI":"10.1177\/1178632920986233"},{"issue":"10","key":"5992_CR21","first-page":"2226","volume":"53","author":"M Aminpour","year":"2024","unstructured":"Aminpour M, Aryankhesal A, Hashjin AA, Pourasghari H. Implementation of the Package of Essential Non-Communicable (PEN) Disease Interventions in Low-Resource Settings: A Systematic Review. Iran J Public Health. 2024;53(10):2226.","journal-title":"Iran J Public Health"},{"issue":"38","key":"5992_CR22","first-page":"1","volume":"15","author":"ZA \u00d6cek","year":"2014","unstructured":"\u00d6cek ZA, \u00c7i\u00e7eklio\u011flu M, Y\u00fccel U, \u00d6zdemir R. Family medicine model in Turkey: a qualitative assessment from the perspectives of primary care workers. BMC Fam Pract. 2014;15(38):1\u201315.","journal-title":"BMC Fam Pract"},{"issue":"12","key":"5992_CR23","doi-asserted-by":"publisher","first-page":"906","DOI":"10.2471\/BLT.20.271239","volume":"98","author":"A Tesema","year":"2020","unstructured":"Tesema A, Joshi R, Abimbola S, Ajisegiri WS, Narasimhan P, Peiris D. Addressing barriers to primary health-care services for noncommunicable diseases in the African Region. Bull World Health Organ. 2020;98(12):906\u20138.","journal-title":"Bull World Health Organ"},{"issue":"5","key":"5992_CR24","doi-asserted-by":"publisher","first-page":"102266","DOI":"10.1016\/j.dsx.2021.102266","volume":"15","author":"JP Tripathy","year":"2021","unstructured":"Tripathy JP, Mishra S. How effective was implementation of the package of essential non-communicable disease (PEN) interventions: A review of evidence? Diabetes Metab Syndr. 2021;15(5):102266.","journal-title":"Diabetes Metab Syndr"},{"issue":"9","key":"5992_CR25","doi-asserted-by":"publisher","first-page":"e074336","DOI":"10.1136\/bmjopen-2023-074336","volume":"13","author":"A Vaidya","year":"2023","unstructured":"Vaidya A, Simkhada P, Lee A, Jones S, Mukumbang FC. Implementing a package of essential non-communicable diseases interventions in low- and middle-income countries: a realist review protocol. BMJ Open. 2023;13(9):e074336.","journal-title":"BMJ Open"},{"issue":"8","key":"5992_CR26","doi-asserted-by":"publisher","first-page":"e0200994","DOI":"10.1371\/journal.pone.0200994","volume":"13","author":"W Mutale","year":"2018","unstructured":"Mutale W, Bosomprah S, Shankalala P, Mweemba O, Chilengi R, Kapambwe S, et al. Assessing capacity and readiness to manage NCDs in primary care setting: Gaps and opportunities based on adapted WHO PEN tool in Zambia. PLoS ONE. 2018;13(8):e0200994.","journal-title":"PLoS ONE"},{"issue":"1","key":"5992_CR27","doi-asserted-by":"publisher","first-page":"2285619","DOI":"10.1080\/16549716.2023.2285619","volume":"16","author":"J Kempers","year":"2023","unstructured":"Kempers J, Rotaru C, Topa A, Zarbailov N, Curteanu A, Prytherch H. Does training on the WHO package of essential noncommunicable (PEN) disease interventions enhance consultation quality? A real-world assessment of adherence to PEN protocol in primary health centres in the Republic of Moldova. Global Health Action. 2023;16(1):2285619.","journal-title":"Global Health Action"},{"issue":"1","key":"5992_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12913-023-09138-8","volume":"23","author":"AF Akinwumi","year":"2023","unstructured":"Akinwumi AF, Esimai OA, Arije O, Ojo TO, Esan OT. Preparedness of primary health care facilities on implementation of essential non-communicable disease interventions in Osun State South-West Nigeria: a rural\u2013urban comparative study. BMC Health Serv Res. 2023;23(1):154.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"5992_CR29","first-page":"19","volume":"36","author":"F Anumah","year":"2024","unstructured":"Anumah F, Ezeigwe N, Mpazanje R, Dewan M, Lawal Y, Omoyele C, et al. Assessment of Primary Healthcare Centres for Care of NonCommunicable Diseases in the Federal Capital Territory, Abuja, Nigeria. J Community Med Prim Health Care. 2024;36(2):19\u201328.","journal-title":"J Community Med Prim Health Care"},{"issue":"6","key":"5992_CR30","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/hpm.3022","volume":"35","author":"AH Albelbeisi","year":"2020","unstructured":"Albelbeisi AH, Albelbeisi A, El Bilbeisi AH, Takian A, Akbari-Sari A. Capacity of palestinian primary health care system to prevent and control of non\u2010communicable diseases in Gaza Strip, Palestine: A capacity assessment analysis based on adapted WHO\u2010PEN tool. Int J Health Plann Manag. 2020;35(6):1412\u201325.","journal-title":"Int J Health Plann Manag"},{"issue":"8","key":"5992_CR31","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2471\/BLT.17.203695","volume":"96","author":"C Bollars","year":"2018","unstructured":"Bollars C, Naseri T, Thomsen R, Varghese C, S\u00f8rensen K, de Vries N, et al. Adapting the WHO package of essential noncommunicable disease interventions. Samoa Bull World Health Organ. 2018;96(8):578.","journal-title":"Samoa Bull World Health Organ"},{"key":"5992_CR32","doi-asserted-by":"crossref","unstructured":"Radwan G, Adawy A. Egyptian health map: a road for evidence-based decision making. Am Soc Clin Oncol. 2018;25(5):350\u201361.","DOI":"10.26719\/emhj.18.048"},{"key":"5992_CR33","doi-asserted-by":"crossref","unstructured":"Mali S, Rhodes EC, Nakarmi CS, Shrestha S, Dhakal A, Bharati A, et al. Barriers and facilitators to patient utilization of non-communicable disease services in primary healthcare facilities in Nepal: a qualitative study. 2025:25(863):1\u201314.","DOI":"10.1186\/s12913-025-13050-8"},{"issue":"2","key":"5992_CR34","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/j.gheart.2016.03.559","volume":"11","author":"P Bovet","year":"2016","unstructured":"Bovet P, Gamra H, Gatumia E, Houinato D, Mondo C, Mohamed A, et al. Availability of guidelines, medications and equipment for cardiovascular disease management at primary health care level in 7 African countries. Global Heart. 2016;11(2):e158\u20139.","journal-title":"Global Heart"},{"issue":"1","key":"5992_CR35","doi-asserted-by":"publisher","first-page":"10272","DOI":"10.1038\/s41598-023-37299-3","volume":"13","author":"M Abbasi-Kangevari","year":"2023","unstructured":"Abbasi-Kangevari M, Ghanbari A, Fattahi N, Malekpour M-R, Masinaei M, Ahmadi N, et al. Tobacco consumption patterns among Iranian adults: a national and sub-national update from the STEPS survey 2021. Sci Rep. 2023;13(1):10272.","journal-title":"Sci Rep"},{"issue":"1","key":"5992_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12939-025-02399-1","volume":"24","author":"A Raeesi","year":"2025","unstructured":"Raeesi A, Hashtarkhani S, Tara M, Sargolzaei N, Kiani B. Empowering access: unveiling an overall composite spatial accessibility index to healthcare services in Southeastern Iran. Int J Equity Health. 2025;24(1):35.","journal-title":"Int J Equity Health"},{"issue":"9810","key":"5992_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0140-6736(11)61678-4","volume":"379","author":"F Habibzadeh","year":"2012","unstructured":"Habibzadeh F. The control of non-communicable diseases in rural Iran. Lancet. 2012;379(9810):6\u20137.","journal-title":"Lancet"},{"issue":"3","key":"5992_CR38","first-page":"23","volume":"9","author":"F Tajari","year":"2021","unstructured":"Tajari F, Mahmoudi G, Dabbaghi F, Yazdani Charati J. Effective Factors in the Establishment and Implementation of Patient Electronic Referral System in the Healthcare System: A Qualitative Study. Iran J Health Sci. 2021;9(3):23\u201334.","journal-title":"Iran J Health Sci"},{"issue":"1","key":"5992_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5334\/gh.1180","volume":"18","author":"N Fahimfar","year":"2023","unstructured":"Fahimfar N, Kohansal K, Asgari S, Ostovar A, Hadaegh F, Khalili D. The Trend of Risk for Cardiovascular Diseases During the Past Decade in Iran, Applying No-Lab and Lab-Based Prediction Models. Glob Heart. 2023;18(1):3.","journal-title":"Glob Heart"},{"issue":"10","key":"5992_CR40","doi-asserted-by":"publisher","first-page":"e20396","DOI":"10.1016\/j.heliyon.2023.e20396","volume":"9","author":"M Momayyezi","year":"2023","unstructured":"Momayyezi M, Sefidkar R, Fallahzadeh H. Agreement between ten-years cardiovascular disease risk assessment tools: An application to Iranian population in Shahedieh Cohort Study. Heliyon. 2023;9(10):e20396.","journal-title":"Heliyon"},{"issue":"2","key":"5992_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.34172\/jcvtr.32906","volume":"16","author":"E Faramarzi","year":"2024","unstructured":"Faramarzi E, Somi M, Ostadrahimi A, Molani-Gol R, Khamnian Z, Ghaffari S, et al. Risk estimation of cardiovascular diseases using the World Health Organization\/International Society of Hypertension risk prediction charts in the Azar cohort population: Cross-sectional study. J Cardiovasc Thorac Res. 2024;16(2):88.","journal-title":"J Cardiovasc Thorac Res"},{"issue":"2","key":"5992_CR42","first-page":"210","volume":"11","author":"N Fahimfar","year":"2020","unstructured":"Fahimfar N, Fotouhi A, Mansournia MA, Malekzadeh R, Sarrafzadegan N, Azizi F, et al. Prediction of cardiovascular disease mortality in a middle eastern country: performance of the Globorisk and score functions in four population-based cohort studies of Iran. Int J Health Policy Manage. 2020;11(2):210.","journal-title":"Int J Health Policy Manage"},{"issue":"11","key":"5992_CR43","doi-asserted-by":"publisher","first-page":"e0292396","DOI":"10.1371\/journal.pone.0292396","volume":"18","author":"M Nomali","year":"2023","unstructured":"Nomali M, Khalili D, Yaseri M, Mansournia MA, Ayati A, Navid H, et al. Validity of the models predicting 10-year risk of cardiovascular diseases in Asia: A systematic review and prediction model meta-analysis. PLoS ONE. 2023;18(11):e0292396.","journal-title":"PLoS ONE"},{"key":"5992_CR44","doi-asserted-by":"publisher","first-page":"111736","DOI":"10.1016\/j.jclinepi.2025.111736","volume":"182","author":"M Nomali","year":"2025","unstructured":"Nomali M, Yaseri M, Nedjat S, Azizi F, Mansournia MA, Navid H, et al. Performance of the revised World Health Organization cardiovascular disease risk prediction models for the Middle East and North Africa: a validation study in the Tehran Lipid and Glucose Study. J Clin Epidemiol. 2025;182:111736.","journal-title":"J Clin Epidemiol"},{"key":"5992_CR45","doi-asserted-by":"crossref","unstructured":"Akhlaghdoust M, Pirani D, Nasiri M, Ahangarani SL, Haghsetan N, Karbalaiea M, et al. Evaluation of cardiovascular diseases risk in the Iranian population. Precision Med Clin OMICS. 2021;1(1):E121308.","DOI":"10.5812\/pmco.121308"},{"issue":"4","key":"5992_CR46","doi-asserted-by":"publisher","first-page":"e023085","DOI":"10.1136\/bmjopen-2018-023085","volume":"9","author":"P Byrne","year":"2019","unstructured":"Byrne P, Cullinan J, Smith A, Smith SM. Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews. BMJ Open. 2019;9(4):e023085.","journal-title":"BMJ Open"},{"issue":"25 Suppl 2","key":"5992_CR47","first-page":"S49","volume":"129","author":"DC Goff","year":"2014","unstructured":"Goff DC, Jr, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R, et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49\u201373.","journal-title":"Circulation"},{"issue":"1","key":"5992_CR48","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41598-024-84366-4","volume":"15","author":"MJ Zibaeenezhad","year":"2025","unstructured":"Zibaeenezhad MJ, Sayadi M, Pourmontaseri H, Khalili D, Farjam M, Bahramail E, et al. Comparison of 10-year atherosclerotic cardiovascular disease (ASCVD) risk in metropolitan and rural areas of South of Iran. Sci Rep. 2025;15(1):550.","journal-title":"Sci Rep"},{"key":"5992_CR49","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ijcard.2015.03.067","volume":"184","author":"D Khalili","year":"2015","unstructured":"Khalili D, Asgari S, Hadaegh F, Steyerberg EW, Rahimi K, Fahimfar N, et al. A new approach to test validity and clinical usefulness of the 2013 ACC\/AHA guideline on statin therapy: a population-based study. Int J Cardiol. 2015;184:587\u201394.","journal-title":"Int J Cardiol"},{"issue":"1","key":"5992_CR50","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12872-024-04242-x","volume":"24","author":"D Khalili","year":"2024","unstructured":"Khalili D, Saadati H, Baradaran HR, Hadaegh F, Steyerberg EW, Woodward M, et al. Optimal risk thresholds for prescribing statins as primary prevention of cardiovascular disease in Iranian general population: a benefit-harm modelling study. BMC Cardiovasc Disord. 2024;24(1):575.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"5992_CR51","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12911-020-01304-w","volume":"20","author":"H Saadati","year":"2020","unstructured":"Saadati H, Baradaran HR, Danaei G, Ostovar A, Hadaegh F, Janani L, et al. Iranian general populations\u2019 and health care providers\u2019 preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease. BMC Med Inf Decis Mak. 2020;20(1):288.","journal-title":"BMC Med Inf Decis Mak"},{"key":"5992_CR52","doi-asserted-by":"crossref","unstructured":"Afkar M, Asl PR, Hezaveh AM, Akrami F, Riazi-Isfahani S, Peykari N, et al. The effect of the COVID-19 pandemic on non-communicable disease prevention and management services in the primary health care system of Iran. Med J Islamic Repub Iran. 2022;36(174):1\u20139.","DOI":"10.47176\/mjiri.36.174"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05992-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:39:05Z","timestamp":1794296345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05992-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5992"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05992-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this ecological and cross-sectional study, we evaluated the performance of the health system using aggregated population-level data. Individual-level data were obtained through secondary analysis of routinely collected health system registries. All data were fully de-identified prior to analysis, and no identifiable personal information was accessible to the research team. The requirement for informed consent to participate was waived by the Research Ethics Committees of Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, in accordance with national research ethics regulations, due to the retrospective use of anonymized registry data. The study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Research Ethics Committees of Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences (IR.SBMU.ENDOCRINE.REC.1402.050).","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"622"}}